Literature DB >> 7006525

Seronegative chronic polyarthritis: clinical and serological correlates.

J L Rasker, P Davis, P A Bacon.   

Abstract

Twenty-seven patients with chronic, active, seronegative polyarthritis were assessed clinically and serologically by accepted criteria for evidence of connective tissue diseases. The patients were divided into 2 groups, 13 positive for fluorescent antinuclear antibody (FANA) and 14 that were negative. All but 1 patient fulfilled the clinical criteria for the diagnosis of definite rheumatoid arthritis. Four patients (2 in each group) fulfilled the preliminary criteria for the classification of systemic lupus erythematosus. Antiperinuclear factor was positive in 5 of the FANA-negative patients, consistent with a diagnosis of rheumatoid arthritis. By contrast, this factor was absent in all the FANA-positive patients. Positive DNA binding was found in 7 of the FANA-positive patients, in high titre in 4, consistent with a diagnosis of 'minimal lupus' with predominantly 'unisystem' disease. DNA binding was positive in low titre in 2 of the FANA-negative patients. Antibodies to extractable nuclear antigens (ENA) were found in 4 patients with a positive FANA and in only 1 FANA-negative patient. The current clinical criteria showed poor discriminatory value in classifying cases of seronegative polyarthritis, which may represent mild cases of other connective tissue disease presenting with synovitis in the absence of extra-articular disease manifestations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7006525      PMCID: PMC1000618          DOI: 10.1136/ard.39.6.550

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Authors:  R L NIENHUIS; E MANDEMA
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

2.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

3.  Analysis of DNA structure by hydroxyapatite columns and ethidium bromide fluorescence techniques. A comparative study and effect on DNA binding.

Authors:  P Davis; M Burrington; A S Russell; A R Morgan
Journal:  Arthritis Rheum       Date:  1978-05

4.  Evaluation of a standardised assay for the measurement of antibodies to double-stranded (native) DNA.

Authors:  P Davis; M Burrington; A R Morgan; A Saetre
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

5.  [Evaluation of the antiperinuclear factor (APF)].

Authors:  R L Nienhuis
Journal:  Ned Tijdschr Geneeskd       Date:  1973-10-20

6.  Significance of persisting serologic abnormalities in SLE.

Authors:  R W Lightfoot; G R Hughes
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

7.  Clinical features of the arthritis of mixed connective tissue disease.

Authors:  J T Halla; J G Hardin
Journal:  Arthritis Rheum       Date:  1978-06

8.  A controlled study of ANA+ RF- arthritis.

Authors:  J E Linn; J G Hardin; J T Halla
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

9.  Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome.

Authors:  A T Masi; J A Maldonado-Cocco; S B Kaplan; S L Feigenbaum; R W Chandler
Journal:  Semin Arthritis Rheum       Date:  1976-05       Impact factor: 5.532

  9 in total
  2 in total

1.  Seronegative polyarthritis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

2.  Evidence for relationships between antiperinuclear and IgG rheumatoid factor.

Authors:  P Youinou; P Le Goff; R Casburn-Budd; C Ferec; Y Pennec
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.